Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Novel fluticasone DPI vs Flutide 250 Diskus in persistent asthma
2006-007073-75Phase 3Terminated
- Sponsor
- mibe GmbH Arzneimittel
- Start
- Dec 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Flixocort in asthma (2 arms), sponsored by mibe GmbH Arzneimittel. Primary endpoint: Primary efficacy criterion. Started Dec 2007; status: terminated.
02
Drugs
Flixocort
03
Conditions
asthma
Beyond the preview
Go deeper on 2006-007073-75.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-007073-75.